Insider Transactions in Q1 2021 at Caladrius Biosciences, Inc. (CLBS)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 14
2021
|
David J Mazzo President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,936
-1.94%
|
$5,936
$1.56 P/Share
|
|
Jan 13
2021
|
David J Mazzo President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
28,212
-4.3%
|
$28,212
$1.55 P/Share
|
|
Jan 13
2021
|
David J Mazzo President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
39,000
+10.47%
|
-
|
|
Jan 11
2021
|
Gregory B Brown Director |
BUY
Grant, award, or other acquisition
|
Direct |
37,735
+31.1%
|
-
|
|
Jan 11
2021
|
Michael H. Davidson Director |
BUY
Grant, award, or other acquisition
|
Direct |
37,735
+20.73%
|
-
|
|
Jan 11
2021
|
Steven M Klosk Director |
BUY
Grant, award, or other acquisition
|
Direct |
37,735
+30.51%
|
-
|
|
Jan 11
2021
|
Steven S Myers Director |
BUY
Grant, award, or other acquisition
|
Direct |
37,735
+25.03%
|
-
|
|
Jan 11
2021
|
Cynthia Schwalm Director |
BUY
Grant, award, or other acquisition
|
Direct |
37,735
+31.94%
|
-
|
|
Jan 11
2021
|
Peter G Traber Director |
BUY
Grant, award, or other acquisition
|
Direct |
37,735
+31.06%
|
-
|
|
Jan 11
2021
|
Anne Clem Whitaker Director |
BUY
Grant, award, or other acquisition
|
Direct |
37,735
+24.35%
|
-
|
|
Jan 11
2021
|
David J Mazzo President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
16,621
-5.34%
|
$16,621
$1.59 P/Share
|
|
Jan 11
2021
|
David J Mazzo President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
119,000
+27.66%
|
-
|
|
Jan 08
2021
|
David J Mazzo President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,726
-2.4%
|
$4,726
$1.6 P/Share
|